Advisors Capital Management, LLC Edwards Lifesciences Corp Transaction History

Advisors Capital Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 16, 2022	SELL	$82.37 - $107.29 $2,882 - $3,755	-35 Reduced 1.13%	3,052 $224,000
Q2 2022 Aug 12, 2022	BUY	$86.5 - $128.27 $37,887 - $56,182	438 Added 16.53%	3,087 $294,000
Q1 2022 May 10, 2022	SELL	$101.96 - $128.34 $25,388 - $31,956	-249 Reduced 8.59%	2,649 $312,000
Q4 2021 Feb 14, 2022	BUY	$106.37 - $130.68 $18,827 - $23,130	177 Added 6.5%	2,898 $375,000
Q3 2021 Nov 12, 2021	BUY	$102.91 - $122.75 $42,090 - $50,204	409 Added 17.69%	2,721 $308,000
Q2 2021 Aug 02, 2021	BUY	$83.84 - $104.76 $193,838 - $242,205	2,312 New	2,312 $239,000
Q1 2021 May 12, 2021	SELL	$78.68 - $90.67 $189,304 - $218,152	-2,406 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$71.69 - $91.23 $172,486 - $219,499	2,406 New	2,406 $219,000
Q1 2020 May 15, 2020	SELL	$52.41 - $81.0 $56,917 - $87,966	-1,086 Closed	0 $0
Q4 2019 Jan 10, 2020	BUY	$71.7 - $82.09 $77,866 - $89,149	1,086 New	1,086 $253,000

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Advisors Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisors Capital Management, LLC with notifications on news.